Evidence map›Paper›PMID 34589870›Full record

ArticleBrain, behavior, & immunity - health2020

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination.

Ahdeah Pajoohesh-Ganji, Molly Karl, Eric Garrison, Nana Adwoa Osei-Bonsu, Cheryl Clarkson-Paredes, Julie Ahn, Robert H Miller

Open access · goldAbstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Brain development and bioenergetic changes.Neurobiology of disease · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ahdeah Pajoohesh-GanjiDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Molly KarlDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Eric GarrisonDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Nana Adwoa Osei-BonsuDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Cheryl Clarkson-ParedesDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Julie AhnDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
Robert H MillerDepartment of Anatomy and Cell Biology, The George Washington University, School of Medicine and Health Sciences, Washington, DC, United States.
George Washington University · US

Funding

Development of Oligodendrycytes in the Spinal CordR01NS030800 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI MILLER, ROBERT H. · 1995 to 2018
$5.7M
NINDS NIH HHS R01 NS030800
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a CNS neurodegenerative autoimmune disease characterized by loss of oligodendrocytes and myelin in the brain and the spinal cord that results in localized functional deficits. Several risk factors have been associated with MS, however none fully explain the enhanced susceptibility seen in older individuals. Epidemiological data, based on geographical prevalence studies suggest that susceptibility is established early in life and frequently long before the diagnosis of disease raising the possibility that developmental events influence adult disease onset and progression. Here we test the hypothesis that selective loss of mature oligodendrocytes during postnatal development results in enhanced susceptibility to a demyelinating insult to the mature CNS. A transgenic mouse model was utilized to specifically induce apoptotic cell death in a subset of mature oligodendrocytes (MBP-iCP9) during the first 2 postnatal weeks followed by either a local LPC spinal cord injection or the induction of EAE in the adult animal. Immunostaining, immunoblotting, behavioral testing, and electron microscopy were utilized to examine the differences in the response between animals with developmental loss of oligodendrocytes and controls. We show that during development, oligodendrocyte apoptosis results in transient reductions in myelination and functional deficits that recover after 10-14 days. Compared to animals in which oligodendrocyte development was unperturbed, animals subjected to postnatal oligodendrocyte loss showed delayed recovery from an LPC lesion to the mature spinal cord. Unexpectedly, the induction and severity of MOG induced EAE was not significantly altered in animals following oligodendrocyte developmental loss even though there was a substantial increase in spinal cord tissue damage and CNS inflammation. It is unclear why the elevated glial responses seen in developmentally compromised animals were not reflected in enhanced functional deficits. These observations suggest that developmental loss of oligodendrocytes results in long lasting tissue changes that alter its response to subsequent insults and the capacity for repair in the adult.

Indexed as

EAEInflammationLPCMultiple sclerosisPriming

Identifiers

PMID34589870
PMCPMC8474627
OpenAlexW3044916005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.